LOGO
LOGO

Earnings News

Symmetricom To Cut 12% Jobs, Lowers Q4 Outlook

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Symmetricom Inc. (SYMM), Tuesday announced a cost-cutting restructuring plan, that includes 12 percent job cuts. The company also lowered its outlook for the fourth quarter.

California-based Symmetricom said the restructuring process is expected to improve its operational and financial efficiency and at the same time maximize resources to support its growth initiatives.

The restructuring plan includes the realignment and consolidation of several organizations, elimination of certain activities, and a workforce reduction of about 12 percent of total headcount.

These actions are commencing immediately and are expected to be complete by December, 2013. Symmetricom expects to incur total charges of $7.5 to $8.0 million, of which about $6.8 million will be in cash. Upon completion, the company expects these actions to generate annual cost savings of about $13 million.

Going ahead, the company lowered its fourth quarter outlook. Symmetricom now expects loss of $0.07 to $0.04 per share, adjusted earnings of $0.05 to $0.07 per share and revenues to be about $51 million.

Previously, the company expects earnings $0.00 to $0.05 per share, adjusted earnings of $0.05 to $0.10 per share and revenues of $51 million to $57 million.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19